Anthony O. Caggiano
Chief Medical OfficerDr. Anthony O. Caggiano, M.D., Ph.D., also known as Tony, is Board Advisor of Gardiner Healthcare Acquisitions Corp. He serves as Chief Medical Officer at Cognition Therapeutics, Inc. since 2021 and also served as its Head of R&D until November 2025. He serves as Member of Advisory Board at Tarix Pharmaceuticals LTD and serves as its Chairman of Advisory Board since 2021. He served as Chief Medical Officer at Cognition Therapeutics, Inc. since June 2019 until January 2021 and serves as its Senior Medical Advisor since January 2021. prior to joining Cognition, Dr. Caggiano was acting president and CMO of Constant Pharmaceuticals and CMO of Aeromics, Inc. He served as Vice President of Research & Development at Acorda Therapeutics, Inc. since February 2009. Dr. Caggiano was responsible for leading the research, development, manufacturing, preclinical testing and early phase clinical planning for these compounds. He served as Vice President of Preclinical Development at Acorda Therapeutics, Inc. since February 2009. He is Chief Medical Officer and Head of Research and Development with NeuroTrauma Sciences. He previously served in various roles in the Preclinical and Research & Development departments since joining Acorda in 2001, directing basic research and product development efforts, coordinating external research efforts with academic and commercial collaborations and collaborating in business development activities. Dr. Caggiano has authored papers in neuro inflammation, injury and recovery and has been the Inventor or Co-inventor on multiple Acorda technologies. Prior to joining Acorda, Dr. Caggiano co-founded Remote Diagnostic Imaging, a company that assembled an expert staff of radiologists to provide remote diagnostic services to understaffed hospitals. Dr. Caggiano holds BA in Biology, Chemistry and Psychology from University of Virginia from 1988 to 1992 and an M.D. and Ph.D. Degrees in Neurobiology, Neuroscience and Medicine from the University of Chicago from 1992 to 1999.
Positions
- Company NameCognition Therapeutics, Inc.Stock CodeCGTXPositionChief Medical OfficerColleagues
- LRLisa RicciardiCEO, President & Director
- JAJack A. KhattarIndependent Chairman of the Board
- JBJohn Brendan DoyleChief Financial Officer
- SASteven A. WeissmanVP & Head of CMC
- ACAnita CornetHead of Quality
- AGAaron Glenn Louis FletcherIndependent Director
- EBEllen B. RichstoneIndependent Director
- MGMichael GrundmanMember of Medical Advisory Board
